United Therapeutics (UTHR) Gains from Investment Securities (2016 - 2026)
United Therapeutics' Gains from Investment Securities history spans 17 years, with the latest figure at $600000.0 for Q4 2025.
- On a quarterly basis, Gains from Investment Securities rose 100.22% to $600000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $16.6 million, a 36.07% increase, with the full-year FY2025 number at $16.6 million, up 36.07% from a year prior.
- Gains from Investment Securities hit $600000.0 in Q4 2025 for United Therapeutics, up from -$237.9 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for UTHR hit a ceiling of $277.8 million in Q3 2024 and a floor of -$277.1 million in Q4 2024.
- Historically, Gains from Investment Securities has averaged -$1.7 million across 5 years, with a median of $200000.0 in 2021.
- Biggest five-year swings in Gains from Investment Securities: plummeted 32050.0% in 2022 and later skyrocketed 263200.0% in 2025.
- Tracing UTHR's Gains from Investment Securities over 5 years: stood at $200000.0 in 2021, then plummeted by 32050.0% to -$63.9 million in 2022, then soared by 86.23% to -$8.8 million in 2023, then crashed by 3048.86% to -$277.1 million in 2024, then surged by 100.22% to $600000.0 in 2025.
- Business Quant data shows Gains from Investment Securities for UTHR at $600000.0 in Q4 2025, -$237.9 million in Q3 2025, and $263.3 million in Q2 2025.